Memmert Universal oven, forced air circulation, fuzzy-PID-controller (Textured Stainless Steel Casing: 550mm x 680mm x 480mm / Interior: 400mm x 400mm x 330mm, 53L), Per Unit
UFE400 Fan forced Universal oven with excellent version controller
Stainless Steel Interior:
Dimensions (W x H x D): 400 x 400 x 330mm
Support ribs for shelves: 4
Shelves supplied with oven: 2
Temperature range: +30ºC to 250°C
Stainless Steel Exterior:
Height (size 800 with castors): 680mm
Depth (without door handle door handle 38mm): 480mm
Electrical load: 1400W
Electrical supply: 230V; 10 AMP
Net weight: 35kg
Excellent version controller features;
Excellent version fuzzy PID control with two integral timers (running time 1 min to 999 h and 7-day-programme timer) and triple thermal protection, fan speed control.
Fuzzy-supported PID microprocessor control and auto-diagnostic system.
Main switch (push/turn) for on/off and (in combination with SET button) for parameter adjustment of set temperature, fan speed, 7-day-programme timer with real-time clock and program timer (1 min to 999 h per segment) for temperature profiles with up to 4 profile segments: wait, heating up, hold (if required, set point dependent), cooling down.
Two high-grade Pt 100 temperature sensors Class A in 4-wire circuit, mutually monitoring and with function switch-over
Visualisation/digital display of all temperature, weekday, speed, ramp segment and set point settings.
Function signals for stand-by, operating mode, heating and fault.
Triple over temperature protection (visual alarm above limit):
1. over temperature due to fault switches off the heating at a fixed margin above the set point
2. Separate digitally-adjustable electronic temperature controller (to special order: adjustable limiter)
3. fixed temperature limiter (TB) switching off above maximum oven temperature
Serial RS 232 computer interface with "Celsius 2005"1) software. Programming, documentation and monitoring functions via PC
Internal data logger 1024 kB as ring store for all set points, actual values, faults, settings with test time and date; documentation capacity approx. 6 months with 1-min intervals.
Works calibration certificate for one temperature (chamber centre) U/S: 160°C, I: 37°C. Convenient recalibration facility without external PC at three selected calibration temperatures.
Markets: Infection Control, Life Sciences, Chemistry & Industry Applications: Equipment, Operating Theatre, Endoscopy, Food & Beverage, Temperature Control, Pharmaceuticals
In Vitro Technologies | Diagnostic Equipment
In Vitro Technologies is a Scientific and Medical distribution company specialising in the sale and support of scientific, clinical diagnostic, medical and related products. The company was established in 2002 and is 100% owned by JJ Richards & Sons Pty Ltd. JJ Richards & Sons Pty Ltd was established in 1932 and is the largest privately owned waste and environmental management company in Australia, with revenues in excess of $300 million and employing over 1,200 employees throughout Australia and New Zealand.
In Vitro Technologies has quickly developed a reputation for being one of the most dynamic and successful companies in the Australian scientific, diagnostic, medical and laboratory consumable supplies and equipment. The company's first acquisition was that of Biotek Ltd in early 2003. Biotek, based in Auckland, has operated in New Zealand for over 20 years as a national distributor for medical and clinical diagnostic products. In 2004 In Vitro Technologies acquired Medos. Medos was established in 1958 and has been a well-known supplier in the Australian scientific and medical market for over 45 years. The combined entity has managed to bring together several key international companies.
Today In Vitro consists of three major Business Units focused on providing our customers with the highest quality products and services in the areas of Scientific, Medical & Diagnostics.
In the future, as in the past In Vitro will be working towards developing strategic alliances with researchers who may require assistance with funding, licensing, product commercialisation and distribution. We are committed to the fact that Australia needs to continue to undertake research, provide world-class healthcare, and ultimately improve health standards in all areas where In Vitro makes a valuable contribution.